News

  • 17 Jan 2014

    icddr,b contributes to influenza vaccine trial

    Researchers at icddr,b, GlaxoSmithKline Biologicals and collaborators in several countries have successfully shown that an inactivated quadrivalent influenza vaccine (QIV) was effective in preventing influenza A or B in children aged three to eight years.
  • 6 Jan 2014

    Season's Greetings from the INDEPTH Executive Director

     All too soon, 2013 will draw to a close. I would like to thank you all for your commitment to INDEPTH and for your various contributions to the work of the network. The end of the year is always a good time to look back and reflect on achievements and challenges; and to...

Pages